The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pretreatment plasma concentrations of YKL-40 and IL-6 in patients with pancreatic cancer: Potential diagnostic and prognostic biomarkers.
Nicolai Aagaard Schultz
No relevant relationships to disclose
Ib Jarle Christensen
No relevant relationships to disclose
Jens Werner
No relevant relationships to disclose
Nathalia Giese
No relevant relationships to disclose
Benny Vittrup Jensen
No relevant relationships to disclose
Ole Larsen
No relevant relationships to disclose
Jon Kroll Bjerregaard
No relevant relationships to disclose
Per Pfeiffer
No relevant relationships to disclose
Dan Calatayud
No relevant relationships to disclose
Svend Erik Nielsen
No relevant relationships to disclose
Mette Yilmaz
No relevant relationships to disclose
Niels Henrik Hollander
No relevant relationships to disclose
Morten Wøjdemann
No relevant relationships to disclose
Stig E. Bojesen
No relevant relationships to disclose
Kaspar Nielsen
No relevant relationships to disclose
Julia S. Johansen
No relevant relationships to disclose